Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice
- 12 June 2009
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 27 (29), 3912-3920
- https://doi.org/10.1016/j.vaccine.2009.04.001
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challengeMucosal Immunology, 2008
- Portable flanking sequences modulate CTL epitope processingJCI Insight, 2007
- Identification of Protective Lassa Virus Epitopes That Are Restricted by HLA-A2Journal of Virology, 2006
- HLA-A∗0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteinsBiochemical and Biophysical Research Communications, 2006
- Lipopeptide epitopes extended by an Nϵ‐palmitoyl‐lysine moiety increase uptake and maturation of dendritic cells through a Toll‐like receptor‐2 pathway and trigger a Th1‐dependent protective immunityEuropean Journal of Immunology, 2004
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceNature, 2004
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responsesImmunology, 2002
- Liposomes as Carriers of Peptide Antigens: Induction of Antibodies and Cytotoxic T Lymphocytes to Conjugated and Unconjugated PeptidesImmunological Reviews, 1995
- Partial purification and some properties of BB7.2 a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28Human Immunology, 1981